The role of renal biopsy in women with kidney disease identified in pregnancy.

Clara Day; Peter Hewins; S Hildebrand; L Sheikh; G Taylor; Mark Kilby; Graham Lipkin

doi:10.1093/ndt/gfm572

The role of renal biopsy in women with kidney disease identified in pregnancy.

Clara Day, Peter Hewins, S Hildebrand, L Sheikh, G Taylor, Mark Kilby, Graham Lipkin

Research output: Contribution to journal › Article

39 Citations (Scopus)

Abstract

BACKGROUND: Renal disease may present for the first time in pregnancy, either as symptomatic disease or as a consequence of antenatal screening. The role of antenatal and post-partum percutaneous renal biopsy in the management of such patients is discussed. METHODS: We describe two series of women; the first is a series of 20 women presenting with renal disease of a severity to warrant renal biopsy during pregnancy whilst the second, comprises 75 women who had an initial presentation of renal disease in pregnancy and underwent post-partum renal biopsy. RESULTS: Biopsy during pregnancy revealed a glomerular disorder in 19/20 (95%) with immediate change of management in 9/20 (40%). In 17/20 (85%) there was delivery of a live infant at median gestation of 36 weeks (range 25-40). Follow-up of women [median 103.3 months (2.5-256)] showed 9/20 (45%) had a GFR of

Original language	English
Pages (from-to)	201-6
Number of pages	6
Journal	Nephrology, Dialysis, Transplantation
Volume	23
Issue number	1
DOIs	https://doi.org/10.1093/ndt/gfm572
Publication status	Published - 1 Jan 2008

Access to Document

10.1093/ndt/gfm572

Cite this

@article{edd2024196b244129b82755f974ab4d7,

title = "The role of renal biopsy in women with kidney disease identified in pregnancy.",

abstract = "BACKGROUND: Renal disease may present for the first time in pregnancy, either as symptomatic disease or as a consequence of antenatal screening. The role of antenatal and post-partum percutaneous renal biopsy in the management of such patients is discussed. METHODS: We describe two series of women; the first is a series of 20 women presenting with renal disease of a severity to warrant renal biopsy during pregnancy whilst the second, comprises 75 women who had an initial presentation of renal disease in pregnancy and underwent post-partum renal biopsy. RESULTS: Biopsy during pregnancy revealed a glomerular disorder in 19/20 (95%) with immediate change of management in 9/20 (40%). In 17/20 (85%) there was delivery of a live infant at median gestation of 36 weeks (range 25-40). Follow-up of women [median 103.3 months (2.5-256)] showed 9/20 (45%) had a GFR of ",

author = "Clara Day and Peter Hewins and S Hildebrand and L Sheikh and G Taylor and Mark Kilby and Graham Lipkin",

year = "2008",

month = jan,

day = "1",

doi = "10.1093/ndt/gfm572",

language = "English",

volume = "23",

pages = "201--6",

journal = "Nephrology, Dialysis, Transplantation",

issn = "1460-2385",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - The role of renal biopsy in women with kidney disease identified in pregnancy.

AU - Day, Clara

AU - Hewins, Peter

AU - Hildebrand, S

AU - Sheikh, L

AU - Taylor, G

AU - Kilby, Mark

AU - Lipkin, Graham

PY - 2008/1/1

Y1 - 2008/1/1

N2 - BACKGROUND: Renal disease may present for the first time in pregnancy, either as symptomatic disease or as a consequence of antenatal screening. The role of antenatal and post-partum percutaneous renal biopsy in the management of such patients is discussed. METHODS: We describe two series of women; the first is a series of 20 women presenting with renal disease of a severity to warrant renal biopsy during pregnancy whilst the second, comprises 75 women who had an initial presentation of renal disease in pregnancy and underwent post-partum renal biopsy. RESULTS: Biopsy during pregnancy revealed a glomerular disorder in 19/20 (95%) with immediate change of management in 9/20 (40%). In 17/20 (85%) there was delivery of a live infant at median gestation of 36 weeks (range 25-40). Follow-up of women [median 103.3 months (2.5-256)] showed 9/20 (45%) had a GFR of

AB - BACKGROUND: Renal disease may present for the first time in pregnancy, either as symptomatic disease or as a consequence of antenatal screening. The role of antenatal and post-partum percutaneous renal biopsy in the management of such patients is discussed. METHODS: We describe two series of women; the first is a series of 20 women presenting with renal disease of a severity to warrant renal biopsy during pregnancy whilst the second, comprises 75 women who had an initial presentation of renal disease in pregnancy and underwent post-partum renal biopsy. RESULTS: Biopsy during pregnancy revealed a glomerular disorder in 19/20 (95%) with immediate change of management in 9/20 (40%). In 17/20 (85%) there was delivery of a live infant at median gestation of 36 weeks (range 25-40). Follow-up of women [median 103.3 months (2.5-256)] showed 9/20 (45%) had a GFR of

U2 - 10.1093/ndt/gfm572

DO - 10.1093/ndt/gfm572

M3 - Article

C2 - 17720987

SN - 1460-2385

VL - 23

SP - 201

EP - 206

JO - Nephrology, Dialysis, Transplantation

JF - Nephrology, Dialysis, Transplantation

IS - 1

ER -

The role of renal biopsy in women with kidney disease identified in pregnancy.

Abstract

Access to Document

Fingerprint

Cite this